Valneva SE (VALN) Non-Current Debt (2020 - 2026)

Valneva SE's (VALN) quarterly Non-Current Debt came in at $192.1 million in Q1 2026, up 13.08% year-on-year from $169.9 million in Q1 2025, and up 2.32% quarter-over-quarter from $187.7 million in Q4 2025.

Valneva SE (VALN) Non-Current Debt (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Non-Current Debt across 7 years of filings, most recently posting $192.1 million for Q1 2026.

  • Non-Current Debt for Q1 2026 came in at $192.1 million, up 13.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $192.1 million (up 13.08% YoY), and the FY2025 annual result was $187.7 million, up 5.49% from the prior year.
  • Non-Current Debt came in at $192.1 million for Q1 2026 at Valneva SE, up from $187.7 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $192.1 million in Q1 2026 to a low of $53.9 million in Q1 2022.
  • The 5-year median for Non-Current Debt is $138.5 million (2025), against an average of $132.1 million.
  • Across the five-year window, Non-Current Debt surged 113.94% in 2024 and fell 24.3% in 2025, its largest moves.
  • Valneva SE's Non-Current Debt stood at $89.0 million in 2022, then surged by 60.52% to $142.9 million in 2023, then gained by 24.57% to $177.9 million in 2024, then rose by 5.49% to $187.7 million in 2025, then increased by 2.32% to $192.1 million in 2026.
  • The last three Non-Current Debt figures came in at $192.1 million (Q1 2026), $187.7 million (Q4 2025), and $127.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 319.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 192.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 192.07 Mn
Mar 31, 2026 192.07 Mn
Dec 31, 2025 187.71 Mn
Dec 31, 2025 187.71 Mn
Sep 30, 2025 127.30 Mn
Sep 30, 2025 127.30 Mn
Jun 30, 2025 138.51 Mn
Jun 30, 2025 138.51 Mn
Mar 31, 2025 169.86 Mn
Mar 31, 2025 169.86 Mn
Dec 31, 2024 177.94 Mn
Dec 31, 2024 177.94 Mn
Sep 30, 2024 168.17 Mn
Sep 30, 2024 168.17 Mn
Jun 30, 2024 172.89 Mn
Jun 30, 2024 172.89 Mn
Mar 31, 2024 172.77 Mn
Mar 31, 2024 172.77 Mn
Dec 31, 2023 142.85 Mn
Dec 31, 2023 142.85 Mn